Hap Trading, LLC Sorrento Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $24,272 - $60,024	32,800 Added 37.7%	119,800 $2,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $11,778 - $22,464	-7,800 Reduced 8.23%	87,000 $9,000
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $2,108 - $3,961	1,700 Added 1.83%	94,800 $20,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $78,400 - $192,080	39,200 Added 72.73%	93,100 $18,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $138,105 - $214,731	29,700 Added 122.73%	53,900 $13,000
Q3 2021 Nov 10, 2021	SELL	$7.41 - $10.99 $22,971 - $34,069	-3,100 Reduced 11.36%	24,200 $16,000
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $17,780 - $28,000	2,800 Added 11.43%	27,300 $44,000
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $321,974 - $756,158	-45,800 Reduced 65.15%	24,500 $40,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $100,800 - $209,125	-17,500 Reduced 19.93%	70,300 $139,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $690,423 - $2.11 Million	-111,900 Reduced 56.03%	87,800 $461,000
Q2 2020 Aug 10, 2020	BUY	$1.73 - $6.76 $345,481 - $1.35 Million	199,700 New	199,700 $536,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.